Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PSMA617-TCMC is a derivative of PSMA-617 with structure modification, in which the caroboxy groups in DOTA ring is replaced by TCMC macrocycle. PSMA-617 is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | Inquiry | $ 789.00 | |
5 mg | Inquiry | $ 1,368.00 |
Description | PSMA617-TCMC is a derivative of PSMA-617 with structure modification, in which the caroboxy groups in DOTA ring is replaced by TCMC macrocycle. PSMA-617 is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. |
Synonyms | PSMA617-TCMC TFA salt, PSMA617-analog, PSMA617-derivative with TCMC, PSMA-617-TCMC |
Molecular Weight | 1659.52 |
Formula | C65H86F12N14O21S |
CAS No. | T28467 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PSMA617-TCMC TFA T28467 PSMA-617-TCMC TFA PSMA617-TCMC TFA salt PSMA617-analog, PSMA617-derivative with TCMC PSMA-617-TCMC PSMA617TCMC TFA PSMA617 TCMC TFA inhibitor inhibit